Brief: MaxCyte Q2 Revenue USD 10.4 Million Vs. IBES Estimate USD 7.92 Million
06/08/2024 21:05
Aug 06 (Reuters) - MaxCyte Q2 gross profit USD 8.9 million. * Q2 cash & investments USD 199.8 million * Q2 adjusted EBITDA USD -10.9 million * Q2 net income USD -9.4 million * Q2 operating expenses USD 20.9 million
Recent news on MaxCyte
See all newsMaxCyte Q1 revenue falls
Brief: Maxcyte Appoints Parmeet Ahuja As Chief Financial Officer
Brief: Maxcyte Announces Preliminary Unaudited Fourth Quarter And Full Year 2025 Financial Results
MaxCyte Q3 revenue falls 16% hurt by lower sales in instruments
Brief: MaxCyte Announces Planned CFO Transition In 2026